PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: quiz answers

TRANSMUCOSAL IMMEDIATE RELEASE FENTANYL …

Initial REMS approval: 12/2011 Most recent modification: /2014 TRANSMUCOSAL IMMEDIATE RELEASE FENTANYL (TIRF) RISK EVALUATION AND MITIGATION STRATEGY (REMS) Page 1 of 16 Reference ID: 3677583 I. GOALS The goals of the TIRF REMS Access program are to mitigate the risk of misuse, abuse, addiction, overdose and serious complications due to medication errors by: 1. Prescribing and dispensing TIRF medicines only to appropriate patients, which includes use only in opioid-tolerant patients. 2. Preventing inappropriate conversion between TIRF medicines. 3. Preventing accidental exposure to children and others for whom it was not prescribed.

Initial REMS approval: 12/2011 Most recent modification: /2014 TRANSMUCOSAL IMMEDIATE RELEASE FENTANYL (TIRF) RISK EVALUATION AND MITIGATION STRATEGY (REMS)

Loading..

Tags:

  Release, Immediate, Fentanyl, Transmucosal immediate release fentanyl, Transmucosal

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of TRANSMUCOSAL IMMEDIATE RELEASE FENTANYL …

Related search queries